Studies related to Subjective Well-Being and Arginine

L-arginine Supplementation In Peripheral Arterial Disease: No Benefit And Possible Harm

Effect None
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 133
Sex Both Genders
Age Range 65+
Notes for this study:
3g arginine daily for 6 months in persons with peripheral artery disease (intermittent claudication in this study) noted that supplementation was actually adverse to blood flow and symptoms of claudition as assessed by functional testing on a treadmill (reducing a 28.3% improvement to 11.5%).